Dr. Kathleen Neuzil leaves the University of Maryland to serve as the Director of NIH’s Fogarty International Center and Dr. Justin Ortiz assumes the role of PI of the UMB CIVICs Clinical Core.
World-renowned influenza immunity and vaccine development expert, Florian Krammer, Ph.D., has assumed a new role as Professor of Infection Medicine at the University of Vienna.
Researchers at CIVR-HRP demonstrated that previously generated data from mouse and ferret studies can be repurposed to produce novel findings. In 2020, they found antigenic distance measures (ADM) correlated to antibody responses and clinical outcomes to influenza vaccination and infection.
CIVR-HRP researchers found that live attenuated versus inactivated influenza vaccines differ in the quality and quantity of immune responses.
Dr. Kevin McCarthy discusses his experience completing a project through the Fall 2023 cycle of the CIVICs Collaborative Training Program.
The CIVICs Network is thrilled to congratulate Dr. Drew Weissman, an investigator who is part of the Duke CIVIC Vaccine Center, on winning the 2023
Coronaviruses and influenza viruses pose a major risk to global health, underscored by the impact of the COVID-19 pandemic and continuing spread of SARS-CoV-2 variants.
The Duke CIVIC Vaccine Center (DCVC) hosted a hybrid annual retreat on May 4 and 5, the second retreat since the contract’s inception in September
The National Institute of Allergy and Infectious Diseases (NIAID) announced that the Duke Human Vaccine Institute (DHVI) has initiated enrollment of volunteers for a clinical
Florian Krammer, Principal Investigator of SEM-CIVIC, was elected to the 2023 Fellowship Class for the American Academy of Microbiology for his significant contributions to the field of microbiology.